Summit Therapeutics, Inc. · 2 days ago
Senior Director, Sales Operations (Oncology)
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life and resolving serious unmet medical needs. The Senior Director of Sales Operations (Oncology) is responsible for building and leading the commercial infrastructure that supports the oncology field force and drives execution excellence.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Lead day-to-day sales operations for the oncology sales organization, ensuring high-quality support and operational readiness
Partner with Sales, Marketing, and Market Access teams to align commercial strategy and field execution priorities
Establish scalable processes to support new launches, new indications, and expansion of the oncology portfolio
Partner cross functionally to develop key performance metrics and dashboards that help the sales organization focus on performance drivers
Lead the design, modeling, and administration of compliant incentive compensation plans, ensuring fairness, clarity, and motivation for the field force
Work directly with cross-functional teams and vendors to coordinate & manage data availability and Q/A process for sales reporting
Deliver sales reports, dashboards, IC scorecards, resource allocation recommendations, and next best recommendations, etc
Manage CRM platforms (e.g., Veeva or Salesforce) including workflows, call plans, segmentation, and reporting capabilities
Develop targeting and segmentation strategies that optimize field execution across oncology HCPs & HCOs
Manage alignment process of territories/regions to maximize effectiveness of the sales force, compliance measures for promotional activity, and IC plan equity
Support digital engagement programs, field-triggered digital content, and omnichannel alignment with marketing ops
Support contracting and execution of all other Field support tools and licenses such as, but not limited to, RxVantage, Mobile Locker, Vendormate, etc
Manage field Fleet program
Manage vendor relationships (CRM, data providers, IC consultants, analytics tools, roster management)
Support commercial data procurement (Outlet level data (DDD/SNR), Dx claims data, oncology datasets, specialty pharmacy/SD channels)
Ensure compliance with legal, regulatory, and quality standards for all field operations activities
All other duties as assigned
Qualification
Required
Bachelor's degree required
Minimum of 12+ years Commercial / Sales Operations experience in the Pharma/Biotech industry
Oncology experience strongly preferred
Deep understanding of oncology market dynamics, data sources, field roles, and buying pathways
Detailed understanding of sales processes, sales data tracking, sales force automation, incentive compensation operations, and sales force alignments
Ability to develop and effectively coach direct reports
Proficient in all aspects of analyzing healthcare sales data and field force activities
Expertise in CRM platforms (Veeva/Salesforce), IC modeling, forecasting, and commercial analytics
Excellent verbal, written and stakeholder management skills to effectively influence and manage expectations with sales management and cross-functional teams
Strong leadership, communication, cross-functional collaboration, and project-management skills
Ability to excel in fast-paced, high-growth biotech environments
Preferred
MBA or advanced degree
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase